Epidemiology of sinonasal undifferentiated carcinoma in Queensland, Australia, 1982-2024: insights from a population-based cohort

Clinical implication of diagnostic and histopathologic discrepancies in sinonasal malignancies

10.1002/lary.29102 · doi-reference

Survivorship needs in patients with head and neck cancer in regional, rural and remote areas: a systematic review

10.1002/pon.9311 · doi-reference

Function, information, and contributions: an evaluation of national multidisciplinary team meetings for rare cancers

10.1177/2036361319841696 · doi-reference

Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet-a population-based study

10.1016/s1470-2045(17)30445-x · doi-reference

Tobacco smoke exposure is a driver of altered oxidative stress response and immunity in head and neck cancer

10.1186/s12967-025-06258-z · doi-reference

Effects of tobacco smoking on the tumor immune microenvironment in head and neck squamous cell carcinoma

10.1158/1078-0432.ccr-19-1769 · doi-reference

Survival outcomes for combined modality therapy for sinonasal undifferentiated carcinoma

10.1177/0194599816670146 · doi-reference

Meta-analysis of multi-modality therapies in sinonasal undifferentiated carcinoma–a timely update

10.1111/coa.14100 · doi-reference

Outcome by treatment modality in sinonasal undifferentiated carcinoma (SNUC): a case-series, systematic review and meta-analysis

10.1016/j.oraloncology.2017.10.008 · doi-reference

Sinonasal undifferentiated carcinoma: clinicopathological spectrums and diagnosis reappraisal

10.1016/j.humpath.2019.04.008 · doi-reference

Induction chemotherapy for locoregionally advanced sinonasal squamous cell carcinoma and sinonasal undifferentiated carcinoma: a comprehensive review

10.3390/cancers15153798 · doi-reference

Sinonasal cancers treatments: state of the art

10.1097/cco.0000000000000726 · doi-reference

The role of radiotherapy in the treatment of sinonasal undifferentiated carcinoma: a population-based analysis

10.1002/hed.27862 · doi-reference

Optimizing treatment de-escalation in head and neck cancer: current and future perspectives

10.1634/theoncologist.2020-0303 · doi-reference

Significance of tumor stage in sinonasal undifferentiated carcinoma survival: a population-based analysis

10.1177/0194599816629649 · doi-reference

Outcomes for sinonasal undifferentiated carcinoma (SNUC): an international multi-center retrospective cohort study

10.3390/cancers18030366 · doi-reference

Sinonasal squamous cell carcinoma: etiology, pathogenesis, and the role of human papilloma virus

10.1007/s40136-020-00279-6 · doi-reference

Treatment outcomes and prognostic factors, including human papillomavirus, for sinonasal undifferentiated carcinoma: a retrospective review

10.1002/hed.23606 · doi-reference

Occupational exposure and sinonasal cancer: a systematic review and meta-analysis

10.1186/s12885-015-1042-2 · doi-reference

Sinonasal undifferentiated carcinoma

10.1007/s11912-019-0776-4 · doi-reference

Sinonasal undifferentiated and poorly differentiated carcinomas: an update

10.1016/j.path.2024.09.004 · doi-reference

Neuroendocrine and undifferentiated sinonasal and skull base tumors: an up-to-date narrative review

10.1007/s10006-024-01240-3 · doi-reference

Sinonasal undifferentiated carcinoma (SNUC): from an entity to morphologic pattern and back again–a historical perspective

10.1097/pap.0000000000000258 · doi-reference